Our society continues to develop and grow despite changes and endless competition. In our daily life, with the help of new technologies such as artificial intelligence and big data, things that were unimaginable in the past are becoming a reality, and industrial sites are becoming increasingly digital and smart.
In particular, in digital transformation (DT), the paradigm of the industry is rapidly changing as the Big Blur phenomenon occurs in which the boundaries of various industries are blurred. DEEPNOID is conducting business with digitalization of analog hospitals, smart healthcare for a healthy life of the people, and non-face-to-face treatment through medical AI and industrial AI technologies and solutions. We are expanding our business in the field of AI.
DEEPNOID strives to create a world where all of us are happy. To become a company that lives together, we fulfill our roles and responsibilities and listen to diverse voices to impress all stakeholders, including customers and shareholders, and to develop 'AI in Everyday Life' so that we can be reborn as a 'company with happy employees'. We will practice it. We will fulfill our responsibility and sense of duty for the advancement of ICT in Korea and global advancement.
We ask for your support, love, and interest in DEEPNOID's powerful footsteps, which always think of new things with an attitude of one-sin-one-one-shin, change and grow on their own.
Thank you.
CEO Woosik Choi
DEEPNOID's Vision
Experience meets passion
DEEPNOID has the optimal conditions for continuous innovation and pursuit of excellence.
Delegation of autonomy and authority
An autonomous work environment based on the Champion scheme provides maximum support for great people to reach their full potential.
Efficient way of working
We actively discuss to find the best solution, and collaborate and execute to solve the most effective problem.
DEEPNOID's History
DEEPNOID aims for a future where anyone can easily understand and utilize artificial intelligence, and we are working towards that future. To this end, DEEPNOID provides a user-driven artificial intelligence (AI) platform (commonly known as DEEP:PHI) and various artificial intelligence (AI) solutions for medical and industrial fields based on it (commonly known as DEEP:AI). DEEPNOID aims to create a world where anyone, regardless of age or gender, can easily develop artificial intelligence models through the DEEP:PHI artificial intelligence platform and AI solutions (medical/industry).
2024
・ Established DEEPNOID Dubai office
・ Signed a business demonstration agreement with Uzbekistan Airport Corporation
・ Signed a 400 million won supply contract with Korea Airports Corporation
・ Signed an 800 million won supply contract for display inspection equipment program development
・ Signed a supply contract worth 485 million won for semiconductor automation equipment program development
・ Presented research abstract on lung cancer screening at the American College of Radiology (ACR)
・ Won the best poster award at the Korean Cancer Association (KCA) conference
・ AI-based thyroid fine-needle aspiration cytology test results published in Thyroid, the official journal of the American Thyroid Association (ATA)
・ 3 research abstracts on AI-based cancer diagnosis technology were accepted by the European Congress of Pathology (ECP)
・ DEEP:NEURO, the first AI solution for brain aneurysm, received provisional listing for non-payment by health insurance
・ Adopted 6 abstracts utilizing medical AI solutions other than DEEP:NEURO at the Korean Congress of Radiology (KCR)
・ Published research paper on utilizing LLM-based AI medical model M4CXR in SCI-level international journal Journal of Clinical Medicine
2023
・ Medical solution DEEP:NEURO selected as Innovative Medical Device - Innovative Medical Technology
・ Published a research paper utilizing artificial intelligence platform DEEP:PHI in the SCI-E international journal Diagnostics
・ Signed a contract for the 4th year of the AI convergence pirated product reading system construction project with Korea Customs Service
・ Installed DEEP:SECURITY (SkyMARU:SECURITY) at 14 airports in Korea
・ Signed a 7.5 billion won supply contract for secondary battery vision system
2022
・Expanded operation of security checkpoints for domestic flights by Korea Airports Corporation (Expanded operation of Gimpo Airport à Gimhae-Jeju-Gwangju)
・Participation in World Security Expo (SECON)
・Prime Minister's Commendation (Science-Information Communication Day commemoration ceremony)
・Participation in AI Expo 2022, International Artificial Intelligence Competition
・Digital Hospital-Smart Healthcare Business Partnership with Chung-Ang University Gwangmyeong Hospital
・DEEPNOID & 'Media Day' held (Vision 2025)
・Korea Airports Corporation technology agreement and SOC technology market certification
2020-2021
・ 2021.08 Listed on KOSDAQ
・ Cooperation with global companies and public institutions (8 institutions including Novartis, Intel, Korea Airports Corporation, Pukyong National University, Pusan National University, etc.)
・ Acquired SOC technology certification (artificial intelligence X-Ray automatic reading system)
・ Attracting KRW 9.4 billion pre-IPO (Hana Financial Investment, etc.)
・ IPO public offering in progress
・ Intel PRTI (Pandemic Response Tech Initiative) funding target project selection
・ Acquisition of medical device manufacturing license
・ Ministry of National Defense AI Medical Imaging System Integration Project
・ Gimpo Airport X-ray automatic reading system pilot operation
・ Indonesia remote cooperation service operation
2017-2019
・ Changed company name to DEEPNOID Co., Ltd.
・ AI company affiliated research institute certification (Korea Industrial Technology Association, No. 2018110735)
・ Series A/B investment of KRW 13 billion
・ Series B 10 billion won investment attraction
・ MOU signed (AI solution test service of Alibaba cloud medical brain and domestic universities)
2008~2016
・ Established Open Business Solution Korea Co., Ltd.
・ Embedded enterprise research institute certification